MURFREESBORO, Tenn., March 13 -- Middle Tennessee State University issued the following news release: MURFREESBORO, Tenn. - Middle Tennessee State University Board of Trustees member and Ole South Pr... Read More
Dhaka, March 13 -- At first sight, the question seems unnecessary. Aren't we all Bengalis, those who speak this tongue, that great language of Bengal called Bangla? Language is considered our identity... Read More
PATNA, March 13 -- Rashtriya Janata Dal (RJD) national working president Tejashwi Yadav on Thursday launched a sharp attack on the Bihar government, alleging that the state has failed on all parameter... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120401) titled 'Effects of neuromuscular electrical stimulation combined with blood flow... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120418) titled 'Effects of Modified Tai Chi Intervention Based on the ICF Framework on ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120422) titled 'The Relationship Between Early Acute Pain After Spinal Surgery and Voice... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120426) titled 'Effect of Dexmedetomidine Nasal Spray on Preoperative Sedation and Emerg... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120430) titled 'A Study on the Health Outcomes of Home Environment Modifications versus ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120434) titled 'Single-arm, multicenter clinical study of Socazolima combined with concu... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120442) titled 'Iparomlimab and Tuvonralimab Combined with Bevacizumab and Chemotherapy ... Read More